IL7 and neoplasm: Unexpectedly, the administration of IL7-Fc exacerbated the growth of B16-F10 melanoma in immune-competent B6 mice (Figure 2B; left panel) but synergistically suppressed tumor growth in mice administered 150 or 300 mkp CTX (Figure 2B; middle and right panels).